NASH PHARMACEUTICALS

Nash Pharmaceuticals is a Canadian drug development company focusing on developing repurposed therapeutic drugs. Drug repurposing (also known as re-profiling, re-tasking or therapeutic switching) is the application of approved drugs and compounds to treat a different disease than what it originally developed for. Nash's business model seeks to minimize investment and drug development risk by taking advantage of regulatory approved drugs and discovering alternative clinical uses by accelerating entry into phase II human clinical trials... Nash Pharmaceuticals Inc is a privately held drug development company focusing on developing repurposed therapeutic drugs. The company has developed data that supports the advancement of up to 7 drug candidates into phase II trials in the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD).

Also known as: Nash Pharmaceuticals Inc